glp-1 and breast cancer risk drugs cut by 30%? Not so fast GLP-1s show 'encouraging' benefit in
Description
Personalized treatment approaches are essential to balance therapeutic benefits with risks
10.1111/acer.13199 61 SorensenG.ReddyI
Kahkoska 1 TJA, G Caleb Alexander 3 4 5, Tellen D Bennett 6, Christopher G Chute 7, Melissa A Haendel 8, Klara R Klein 9, Hemalkumar Mehta 3 4, Joshua D Miller 10, Richard A Moffitt 11, Til Strmer 12, Kajsa Kvist 2, John B Buse, N3C consortium
Tashiro et al
Discrepancies in species-specific drug metabolism, receptor distribution, and behavioral repertoire may lead to both false positives and negatives
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Nylander M, Frssing S, Kistorp C, Faber J, Skouby SO
